Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002725 2013-02-05

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Phase 2 Completed

35 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00388895 2008-11-19

Glivec in Ph Positive Lymphoblastic Leukemia

Phase 2 Completed

35 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

LAL2317

UKALL60+

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Glivec in Ph Positive Lymphoblastic Leukemia